Pathway enrichment analysis of these DMGs identified key metabolic and signaling pathways, including PI3K-Akt, Hippo signaling, and focal adhesion, which are critical in liver metabolism and MASLD progression (Figure 5G). This evidence concerns the gene AKT1 and metabolic dysfunction-associated steatotic liver disease.